Alternative therapies for the prevention and treatment of osteoporosis

Nutrition Reviews

Volumn 70, Issue 1, 2012, Pages 22-40

  Banu, Jameela ^a,b   Varela, Erika ^b   Fernandes, Gabriel ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Fatty acids; Osteoporosis; Plants and plant compounds

Indexed keywords

ALENDRONIC ACID; ALLIUM CEPE EXTRACT; ANEMARRHENA ASPHODELOIDES EXTRACT; ANGELICA SINENSIS EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; CONJUGATED ESTROGEN; CURCULIGO ORCHIOIDES EXTRACT; DENOSUMAB; DIOSCOREA SPONGIOSA EXTRACT; ESTRADIOL PLUS NORETHISTERONE ACETATE; GARLIC EXTRACT; GESTAGEN; GLYCINE MAX EXTRACT; GREEN TEA EXTRACT; IBANDRONIC ACID; MORINDA OFFICINALIS EXTRACT; OLEA EUROPAEA EXTRACT; ONION EXTRACT; PAMIDRONIC ACID; PARATHYROID HORMONE[1-34]; PLANT EXTRACT; RALOXIFENE; REHMANNIA GULTINOSA EXTRACT; RHIZOMA CURCULIGINUS EXTRACT; RISEDRONIC ACID; ROSMARINUS OFFICINALIS EXTRACT; SAFFLOWER EXTRACT; SALVIA OFFICINALIS EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZOLEDRONIC ACID;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BEAN; BLOOD CLOT; BONE MINERAL; BONE MINERALIZATION; BONE NECROSIS; BONE REMODELING; BONE TURNOVER; BREAST CANCER; CURCULIGO ORCHIOIDES; DIET SUPPLEMENTATION; DIOSCOREA SPONGIOSA; ECZEMA; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FRUIT; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; MEDICINAL PLANT; NAUSEA; NEOPLASM; NEPHROTOXICITY; NONHUMAN; ONION; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PLANT LEAF; PLANT ROOT; PLANT SEED; PLANT STEM; REHMANNIA GULTINOSA; RESPIRATORY TRACT INFECTION; RHIZOMA CURCULIGINUS; RHIZOME; SIDE EFFECT; STROKE; URINARY TRACT INFECTION;

BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; MALE; OSTEOPOROSIS; PHYTOTHERAPY; PLANT EXTRACTS; TREATMENT OUTCOME;

ASTERACEAE; FABACEAE; OLEACEAE; RANUNCULACEAE; ROSACEAE; VITACEAE; ZINGIBERACEAE;

EID: 84855384076     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2011.00451.x     Document Type: Article

References (161)

1. Canalis E. Novel treatments for osteoporosis. J Clin Invest. 2000;106:177-179.
2. Ray NF, Chan JK, Thamer M, Melton LJ, 3rd. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:24-35.
3. Johnell O. The socioeconomic burden of fractures: today and in the 21st century. Am J Med. 1997;103 (Suppl):S20-S25; discussion S25-S26.
4. Kalu DN. Animal models of the aging skeleton. In: Rosen CJ, Glowacki J, Bilezikian JP, eds. The Aging Skeleton. San Diego: Academic Press; 1999:37-50.
5. Bonnick SaL LA. An Overview of Osteoporosis. New York: Humana Press; 2006.
6. Nichols DL, Bonnick SL, Sanborn CF. Bone health and osteoporosis. Clin Sports Med. 2000;19:233-249.
7. McGarry KA, Kiel DP. Postmenopausal osteoporosis. Strategies for preventing bone loss, avoiding fracture. Postgrad Med. 2000;108:79-91.
8. Riggs BL, Khosla S, Melton LJ, 3rd. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998;13:763-773.
9. Riggs BL, Khosla S, Melton LJ, 3rd. Primary osteoporosis in men: role of sex steroid deficiency. Mayo Clin Proc. 2000;75(Suppl):S46-S50.
10. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res. 1988;175:266-276.
11. Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech. 2003;61:504-513.
12. Reddy SV. Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr. 2004;14:255-270.
13. Kohlmeir L. Osteoporosis update: Preventional treatment. Drug Benefit Trends. 1999;11:433-454.
14. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985;102:319-324.
15. Gambacciani M, Ciaponi M, Cappagli B, etal. Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy. Maturitas. 2003;45:175-183.
16. Foidart JM, Desreux J, Pintiaux A, Gompel A. Hormone therapy and breast cancer risk. Climacteric. 2007;10(Suppl 2):S54-S61.
17. Persson I, Weiderpass E, Bergkvist L, Bergstrom R, Schairer C. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control. 1999;10:253-260.
18. Bock O, Felsenberg D. Bisphosphonates in the management of postmenopausal osteoporosis - optimizing efficacy in clinical practice. Clin Interv Aging. 2008;3:279-297.
19. Compston J. Clinical and therapeutic aspects of osteoporosis. Eur J Radiol. 2009;71:388-391.
20. Papapetrou PD. Bisphosphonate-associated adverse events. Hormones (Athens). 2009;8:96-110.
21. Strampel W, Emkey R, Civitelli R. Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf. 2007;30:755-763.
22. Nelson Al, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody. Nat Rev Drug Discov. 2010;9:767-774.
23. Committee for Medicinal Products for Human Use. Summary of Positive Opinion for Prolia. European Medicines Agency. 2009 Available at:. Accessed 20 January 2011.
24. Cummings SR, San Martin J, McClung MR, etal. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756-765.
25. McClung MR, Lewiecki EM, Cohen SB, etal. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006;354:821-831.
26. Rosen CJ, Rackoff PJ. Emerging anabolic treatments for osteoporosis. Rheum Dis Clin North Am. 2001;27:215-233, viii.
27. Crandall C. Parathyroid hormone for treatment of osteoporosis. Arch Intern Med. 2002;162:2297-2309.
28. Feldman RS, Krieger NS, Tashjian AH, Jr. Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro. Endocrinology. 1980;107:1137-1143.
29. Raisz LG. Mechanism of bone resorption. In: Aurbach GD, ed. Handbook of Physiology. Washington, DC: American Physiological Society; 1976:Section 7, 117-136.
30. Stewart PJ, Stern PH. Vertebral bone resorption in vitro: effects of parathyroid hormone, calcitonin, 1, 25 dihydroxyvitamin D3, epidermal growth factor, prostaglandin E2, and estrogen. Calcif Tissue Int. 1987;40:21-26.
31. Muhlbauer RC, Lozano A, Palacio S, Reinli A, Felix R. Common herbs, essential oils, and monoterpenes potently modulate bone metabolism. Bone. 2003;32:372-380.
32. Wetli HA, Brenneisen R, Tschudi I, etal. A gamma-glutamyl peptide isolated from onion (Allium cepa L.) by bioassay-guided fractionation inhibits resorption activity of osteoclasts. J Agric Food Chem. 2005;53:3408-3414.
33. Mukherjee M, Das AS, Mitra S, Mitra C. Prevention of bone loss by oil extract of garlic (Allium sativum Linn.) in an ovariectomized rat model of osteoporosis. Phytother Res. 2004;18:389-394.
34. Huh J. Dongeui Herbe. Vol. 3. Seoul, Korea: Yeogang Publisher; 1989:2763.
35. Jang HO, Park YS, Lee JH, etal. Effect of extracts from safflower seeds on osteoblast differentiation and intracellular calcium ion concentration in MC3T3-E1 cells. Nat Prod Res. 2007;21:787-797.
36. Kim HJ, Bae YC, Park RW, etal. Bone-protecting effect of safflower seeds in ovariectomized rats. Calcif Tissue Int. 2002;71:88-94.
37. Lee YS, Choi CW, Kim JJ, Ganapathi A, Udayakumar R, Kim SC. Determination of mineral content in methanolic safflower (Carthamus tinctorius L.) seed extract and its effect on osteoblast markers. Int J Mol Sci. 2009;10:292-305.
38. Alam MR, Kim SM, Lee JI, etal. Effects of safflower seed oil in osteoporosis-induced ovariectomized rats. Am J Chin Med. 2006;34:601-612.
39. Shen CL, Yeh JK, Cao JJ, Wang JS. Green tea and bone metabolism. Nutr Res. 2009;29:437-456.
40. Pagnotta E, Calonghi N, Hrelia S, Masotti L, Biagi P, Angeloni C. Green tea protects cytoskeleton from oxidative injury in cardiomyocytes. J Agric Food Chem. 2006;54:10159-10163.
41. Chen CH, Ho ML, Chang JK, Hung SH, Wang GJ. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int. 2005;16:2039-2045.
42. Hayashi K, Takai S, Matsushima-Nishiwaki R, etal. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts. Life Sci. 2008;82:1012-1017.
43. Mount JG, Muzylak M, Allen S, Althnaian T, McGonnell IM, Price JS. Evidence that the canonical Wnt signalling pathway regulates deer antler regeneration. Dev Dyn. 2006;235:1390-1399.
44. Das AS, Das D, Mukherjee M, Mukherjee S, Mitra C. Phytoestrogenic effects of black tea extract (Camellia sinensis) in an oophorectomized rat (Rattus norvegicus) model of osteoporosis. Life Sci. 2005;77:3049-3057.
45. Delaisse JM, Eeckhout Y, Vaes G. Inhibition of bone resorption in culture by (+)-catechin. Biochem Pharmacol. 1986;35:3091-3094.
46. Nakagawa H, Wachi M, Woo JT, etal. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun. 2002;292:94-101.
47. Tokuda H, Takai S, Hanai Y, etal. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation. FEBS Lett. 2007;581:1311-1316.
48. Yun JH, Kim CS, Cho KS, Chai JK, Kim CK, Choi SH. (-)-Epigallocatechin gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from RAW 264.7 cells. J Periodontal Res. 2007;42:212-218.
49. Anderson JJ, Anthony MS, Cline JM, etal. Health potential of soy isoflavones for menopausal women. 1999;2:489-504.
50. Devareddy L, Khalil DA, Korlagunta K, Hooshmand S, Bellmer DD, Arjmandi BH. The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats. Menopause. 2006;13:692-699.
51. Soung DY, Devareddy L, Khalil DA, etal. Soy affects trabecular microarchitecture and favorably alters select bone-specific gene expressions in a male rat model of osteoporosis. Calcif Tissue Int. 2006;78:385-391.
52. Arjmandi BH, Smith BJ. Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem. 2002;13:130-137.
53. Arjmandi BH, Lucas EA, Khalil DA, etal. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr J. 2005;4:8.
54. Wang SF, Jiang Q, Ye YH, Li Y, Tan RX. Genistein derivatives as selective estrogen receptor modulators: sonochemical synthesis and in vivo anti-osteoporotic action. Bioorg Med Chem. 2005;13:4880-4890.
55. Pan W, Quarles LD, Song LH, etal. Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow culture. J Cell Biochem. 2005;94:307-316.
56. Dai R, Ma Y, Sheng Z, etal. Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats. J Bone Miner Metab. 2008;26:342-349.
57. Fonseca D, Ward WE. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone. 2004;35:489-497.
58. Somjen D, Yoles I. DT56a (Tofupill/Femarelle) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus. J Steroid Biochem Mol Biol. 2003;86:93-98.
59. Zhang Y, Lai WP, Leung PC, Wu CF, Yao XS, Wong MS. Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol Pharm Bull. 2006;29:291-296.
60. Zhang Y, Dong XL, Leung PC, Che CT, Wong MS. Fructus ligustri lucidi extract improves calcium balance and modulates the calciotropic hormone level and vitamin D-dependent gene expression in aged ovariectomized rats. Menopause. 2008;15:558-565.
61. Zhang Y, Lai WP, Leung PC, Che CT, Wong MS. Improvement of Ca balance by Fructus Ligustri Lucidi extract in aged female rats. Osteoporos Int. 2008;19:235-242.
62. Zhang Y, Leung PC, Che CT, Chow HK, Wu CF, Wong MS. Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus Ligustri Lucidi. Br J Nutr. 2008;99:494-502.
63. Ko CH, Siu WS, Lau CP, Lau CB, Fung KP, Leung PC. Osteoprotective effects of Fructus Ligustri Lucidi aqueous extract in aged ovariectomized rats. Chin Med. 2010;5:39.
64. Saleh NK, Saleh HA. Olive oil effectively mitigates ovariectomy-induced osteoporosis in rats. BMC Complement Altern Med. 2011;11:10.
65. Franklin M, Bu SY, Lerner MR, etal. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. Bone. 2006;39:1331-1342.
66. Bu SY, Lucas EA, Franklin M, etal. Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats. Osteoporos Int. 2007;18:931-942.
67. Arjmandi BH, Khalil DA, Lucas EA, etal. Dried plums improve indices of bone formation in postmenopausal women. J Womens Health Gend Based Med. 2002;11:61-68.
68. Altan MF, Kanter M, Donmez S, Kartal ME, Buyukbas S. Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats. Acta Histochem. 2007;109:304-314.
69. Altan MF. Effects of Nigella sativa and human parathyroid hormone on bone mass and strength in diabetic rats. Biol Trace Elem Res. 2007;116:321-328.
70. Nisslein T, Freudenstein J. Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. J Bone Miner Metab. 2003;21:370-376.
71. Seidlova-Wuttke D, Jarry H, Pitzel L, Wuttke W. Effects of estradiol-17beta, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats. Maturitas. 2005;51:177-186.
72. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas. 2003;44(Suppl 1):S67-S77.
73. Singh LM, Udupa KN. Studies on "Cissus quadrangularis" in fracture by using phosphorus 32. III. Indian J Med Sci. 1962;16:926-931.
74. Irving JT. Theories of mineralization of bone. Clin Orthop Relat Res. 1973;97:225-236.
75. Udupa KN, Prasad G. Biomechanical and calcium-45 studies on the effect of Cissus quadrangularis in fracture repair. Indian J Med Res. 1964;52:480-487.
76. Shirwaikar A, Khan S, Malini S. Antiosteoporotic effect of ethanol extract of Cissus quadrangularis Linn. on ovariectomized rat. J Ethnopharmacol. 2003;89:245-250.
77. Potu BK, Rao MS, Nampurath GK, etal. Evidence-based assessment of antiosteoporotic activity of petroleum-ether extract of Cissus quadrangularis Linn. on ovariectomy-induced osteoporosis. Ups J Med Sci. 2009;114:140-148.
78. Potu BK, Rao MS, Kutty NG, Bhat KM, Chamallamudi MR, Nayak SR. Petroleum ether extract of Cissus quadrangularis (LINN) stimulates the growth of fetal bone during intra uterine developmental period: a morphometric analysis. Clinics (Sao Paulo). 2008;63:815-820.
79. Parisuthiman D, Singhatanadgit W, Dechatiwongse T, Koontongkaew S. Cissus quadrangularis extract enhances biomineralization through up-regulation of MAPK-dependent alkaline phosphatase activity in osteoblasts. In Vitro Cell Dev Biol Anim. 2009;45:194-200.
80. Muthusami S, Senthilkumar K, Vignesh C, etal. Effects of Cissus quadrangularis on the proliferation, differentiation and matrix mineralization of human osteoblast like SaOS-2 cells. J Cell Biochem. 2011;112:1035-1045.
81. Zhou H, Shang L, Li X, etal. Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. Exp Cell Res. 2009;315:2953-2962.
82. Wilkinson JM. Effect of ginger tea on the fetal development of Sprague-Dawley rats. Reprod Toxicol. 2000;14:507-512.
83. Bharti AC, Takada Y, Aggarwal BB. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol. 2004;172:5940-5947.
84. Yang MW, Wang TH, Yan PP, etal. Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice. Phytomedicine. 2011;18:205-213.
85. Tylavsky FA, Holliday K, Danish R, Womack C, Norwood J, Carbone L. Fruit and vegetable intakes are an independent predictor of bone size in early pubertal children. Am J Clin Nutr. 2004;79:311-317.
86. Vatanparast H, Baxter-Jones A, Faulkner RA, Bailey DA, Whiting SJ. Positive effects of vegetable and fruit consumption and calcium intake on bone mineral accrual in boys during growth from childhood to adolescence: the University of Saskatchewan Pediatric Bone Mineral Accrual Study. Am J Clin Nutr. 2005;82:700-706.
87. Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol. 2008;214:201-209.
88. Poulsen RC, Wolber FM, Moughan PJ, Kruger MC. Long-chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells. Prostaglandins Other Lipid Mediat. 2008;85:42-48.
89. Zeitlin L, Segev E, Fried A, Wientroub S. Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice. J Cell Biochem. 2003;90:347-360.
90. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res. 2003;18:1206-1216.
91. Baggio B. Fatty acids, calcium and bone metabolism. J Nephrol. 2002;15:601-604.
92. Kruger MC, Schollum LM. Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability? Prostaglandins Leukot Essent Fatty Acids. 2005;73:327-334.
93. Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J. 2007;6:2.
94. Bhattacharya A, Rahman M, Sun D, Fernandes G. Effect of fish oil on bone mineral density in aging C57BL/6 female mice. J Nutr Biochem. 2007;18:372-379.
95. Schlemmer CK, Coetzer H, Claassen N, Kruger MC. Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat. Prostaglandins Leukot Essent Fatty Acids. 1999;61:381-390.
96. Watkins BA, Li Y, Seifert MF. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem. 2006;17:282-289.
97. Korotkova M, Ohlsson C, Hanson LA, Strandvik B. Dietary n-6:n-3 fatty acid ratio in the perinatal period affects bone parameters in adult female rats. Br J Nutr. 2004;92:643-648.
98. Matsushita H, Barrios JA, Shea JE, Miller SC. Dietary fish oil results in a greater bone mass and bone formation indices in aged ovariectomized rats. J Bone Miner Metab. 2008;26:241-247.
99. Reinwald S, Li Y, Moriguchi T, Salem N, Jr. Watkins BA. Repletion with (n-3) fatty acids reverses bone structural deficits in (n-3)-deficient rats. J Nutr. 2004;134:388-394.
100. Corwin RL. Effects of dietary fats on bone health in advanced age. Prostaglandins Leukot Essent Fatty Acids. 2003;68:379-386.
101. Watkins BA, Li Y, Lippman HE, Seifert MF. Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med (Maywood). 2001;226:485-497.
102. Weiler HA, Fitzpatrick-Wong SC. Modulation of essential (n-6):(n-3) fatty acid ratios alters fatty acid status but not bone mass in piglets. J Nutr. 2002;132:2667-2672.
103. Weiler HA. Dietary supplementation of arachidonic acid is associated with higher whole body weight and bone mineral density in growing pigs. Pediatr Res. 2000;47:692-697.
104. Liu D, Veit HP, Wilson JH, Denbow DM. Long-term supplementation of various dietary lipids alters bone mineral content, mechanical properties and histological characteristics of Japanese quail. Poult Sci. 2003;82:831-839.
105. Shen CL, Yeh JK, Rasty J, etal. Improvement of bone quality in gonad-intact middle-aged male rats by long-chain n-3 polyunsaturated fatty acid. Calcif Tissue Int. 2007;80:286-293.
106. Hogstrom M, Nordstrom P, Nordstrom A. n-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 Study. Am J Clin Nutr. 2007;85:803-807.
107. Ward WE, Fonseca D. Soy isoflavones and fatty acids: effects on bone tissue postovariectomy in mice. Mol Nutr Food Res. 2007;51:824-831.
108. Blanaru JL, Kohut JR, Fitzpatrick-Wong SC, Weiler HA. Dose response of bone mass to dietary arachidonic acid in piglets fed cow milk-based formula. Am J Clin Nutr. 2004;79:139-147.
109. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006;17:789-810.
110. Jewell C, Cashman KD. The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells. Br J Nutr. 2003;89:639-647.
111. Rahman MM, Bhattacharya A, Fernandes G. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling. J Lipid Res. 2006;47:1739-1748.
112. Platt I, El-Sohemy A. Effects of 9cis, 11trans and 10trans, 12cis CLA on osteoclast formation and activity from human CD14+ monocytes. Lipids Health Dis. 2009;8:15.
113. Banu J, Bhattacharya A, Rahman M, Fernandes G. Beneficial effects of conjugated linoleic acid and exercise on bone of middle-aged female mice. J Bone Miner Metab. 2008;26:436-445.
114. Kelly O, Cashman KD. The effect of conjugated linoleic acid on calcium absorption and bone metabolism and composition in adult ovariectomised rats. Prostaglandins Leukot Essent Fatty Acids. 2004;71:295-301.
115. Brownbill RA, Petrosian M, Ilich JZ. Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. J Am Coll Nutr. 2005;24:177-181.
116. Banu J, Bhattacharya A, Rahman M, O'Shea M, Fernandes G. Effects of conjugated linoleic acid and exercise on bone mass in young male Balb/C mice. Lipids Health Dis. 2006;5:7.
117. Li Y, Seifert MF, Ney DM, etal. Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res. 1999;14:1153-1162.
118. Dawson-Hughes B. Interaction of dietary calcium and protein in bone health in humans. J Nutr. 2003;133(Suppl):S852-S854.
119. Vicente-Rodriguez G, Ezquerra J, Mesana MI, etal. Independent and combined effect of nutrition and exercise on bone mass development. J Bone Miner Metab. 2008;26:416-424.
120. Popkin BM. Nutrition in transition: the changing global nutrition challenge. Acta Pacific J Clin Nutr. 2001;10:S13-S18.
121. Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutrition Rev. 1997;55:31-43.
122. Weaver CM. The growing years and prevention of osteoporosis in later life. Proc Nutr Soc. 2000;59:303-306.
123. Weaver CM. Calcium requirements of physically active people. Am J Clin Nutr. 2000;72(Suppl):S579-S584.
124. Morgan SL. Nutrition and bone: it is more than calcium and vitamin D. Womens Health (Lond Engl). 2009;5:727-737.
125. Tucker KL. Dietary intake and bone status with aging. Curr Pharm Des. 2003;9:2687-2704.
126. Fernandes G, Lawrence R, Sun D. Protective role of n-3 lipids and soy protein in osteoporosis. Prostaglandins Leukot Essent Fatty Acids. 2003;68:361-372.
127. Ruxton C. Health benefits of omega-3 fatty acids. Nurs Stand. 2004;18:38-42.
128. Kaul N, Kreml R, Austria JA, etal. A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J Am Coll Nutr. 2008;27:51-58.
129. Igarashi T, Aursand M, Sacchi R, Paolillo L, Nonaka M, Wada S. Determination of docosahexaenoic acid and n-3 fatty acids in refined fish oils by 1H-NMR spectroscopy: IUPAC interlaboratory study. J AOAC Int. 2002;85:1341-1354.
130. Bunea R, El Farrah K, Deutsch L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev. 2004;9:420-428.
131. Venkatraman JT, Chandrasekar B, Kim JD, Fernandes G. Effects of n-3 and n-6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune-prone NZBxNZW F1 mice. Lipids. 1994;29:561-568.
132. Brenner D. Perilla: botany, uses and genetic resources. In: Janick J, Simon JE, eds. New Crops. New York: Wiley; 1993:322-328.
133. Jainu M, Devi CS. Gastroprotective action of Cissus quadrangularis extract against NSAID induced gastric ulcer: role of proinflammatory cytokines and oxidative damage. Chem Biol Interact. 2006;161:262-270.
134. Yang Q, Populo SM, Zhang J, Yang G, Kodama H. Effect of Angelica sinensis on the proliferation of human bone cells. Clin Chim Acta. 2002;324:89-97.
135. Qin LP, Zhang QY, Tian YP, Zheng HC, Haung M, Huang BK. Total coumarins from fruits of Cnidium monnieri inhibit formation and differentiation of multinucleated osteoclasts of rats. Acta Pharmacol Sin. 2003;24:181-186.
136. Nian H, Qin LP, Chen WS, Zhang QY, Zheng HC, Wang Y. Protective effect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-induced bone loss in rats. Acta Pharmacol Sin. 2006;27:728-734.
137. Wong RW, Rabie B, Bendeus M, Hagg U. The effects of Rhizoma curculiginis and Rhizoma drynariae extracts on bones. Chin Med. 2007;2:13.
138. Cao DP, Zheng YN, Qin LP, etal. Curculigo orchioides, a traditional Chinese medicinal plant, prevents bone loss in ovariectomized rats. Maturitas. 2008;59:373-380.
139. Jiao L, Cao DP, Qin LP, etal. Antiosteoporotic activity of phenolic compounds from Curculigo orchioides. Phytomedicine. 2009;16:874-881.
140. Kim KW, Suh SJ, Lee TK, etal. Effect of safflower seeds supplementation on stimulation of the proliferation, differentiation and mineralization of osteoblastic MC3T3-E1 cells. J Ethnopharmacol. 2008;115:42-49.
141. Yuk TH, Kang JH, Lee SR, etal. Inhibitory effect of Carthamus tinctorius L. seed extracts on bone resorption mediated by tyrosine kinase, COX-2 (cyclooxygenase) and PG (prostaglandin) E2. Am J Chin Med. 2002;30:95-108.
142. Yin J, Kouda K, Tezuka Y, etal. Steroidal glycosides from the rhizomes of Dioscorea spongiosa. J Nat Prod. 2003;66:646-650.
143. Kim C, Ha H, Lee JH, Kim JS, Song K, Park SW. Herbal extract prevents bone loss in ovariectomized rats. Arch Pharm Res. 2003;26:917-924.
144. Devareddy L, Khalil DA, Smith BJ, etal. Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Bone. 2006;38:686-693.
145. Roudsari AH, Tahbaz F, Hossein-Nezhad A, Arjmandi B, Larijani B, Kimiagar SM. Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial. Nutr J. 2005;4:30.
146. Arjmandi BH, Khalil DA, Smith BJ, etal. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab. 2003;88:1048-1054.
147. Li N, Qin LP, Han T, Wu YB, Zhang QY, Zhang H. Inhibitory effects of Morinda officinalis extract on bone loss in ovariectomized rats. Molecules. 2009;14:2049-2061.
148. Wu YB, Zheng CJ, Qin LP, etal. Antiosteoporotic activity of anthraquinones from Morinda officinalis on osteoblasts and osteoclasts. Molecules. 2009;14:573-583.
149. Oh KO, Kim SW, Kim JY, etal. Effect of Rehmannia glutinosa Libosch extracts on bone metabolism. Clin Chim Acta. 2003;334:185-195.
150. Puel C, Mathey J, Kati-Coulibaly S, etal. Preventive effect of Abelmoschus manihot (L.) Medik. on bone loss in the ovariectomised rats. J Ethnopharmacol. 2005;99:55-60.
151. Mori-Okamoto J, Otawara-Hamamoto Y, Yamato H, Yoshimura H. Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice. J Ethnopharmacol. 2004;92:93-101.
152. 3 and its metabolites in the tomato plant. Phytochemistry. 1996;42:617-620.
153. Hong HT, Kim HJ, Lee TK, etal. Inhibitory effect of a Korean traditional medicine, Honghwain-Jahage (water extracts of Carthamus tinctorius L. seed and Hominis placenta) on interleukin-1-mediated bone resorption. J Ethnopharmacol. 2002;79:143-148.
154. Tripathi YB, Singh AV. Role of Rubia cordifolia Linn. in radiation protection. Indian J Exp Biol. 2007;45:620-625.
155. Reddy NP, Lakshmana M, Udupa UV. Antiosteoporotic activity of OST-6(Osteocare), a herbomineral preparation in calcium-deficient ovariectomized rats. Phytother Res. 2004;18:25-29.
156. Xu M, Dick IM, Day R, Randall D, Prince RL. Effects of a herbal extract on the bone density, strength and markers of bone turnover of mature ovariectomized rats. Am J Chin Med. 2003;31:87-101.
157. Li JX, Liu J, He CC, etal. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss. Maturitas. 2007;58:59-69.
158. Lee SU, Park SJ, Kwak HB, Oh J, Min YK, Kim SH. Anabolic activity of ursolic acid in bone: stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo. Pharmacol Res. 2008;58:290-296.
159. Deyhim F, Smith BJ, Soung DY, Juma S, Devareddy L, Arjmandi BH. Ipriflavone modulates IGF-I but is unable to restore bone in rats. Phytother Res. 2005;19:116-120.
160. Banu J, Bhattacharya A, Rahman M, O'Shea M, Fernandes G. Effects of conjugated linoleic acid and exercise on bone mass in young male Balb/C mice. Lipids Health Dis. 2006;5:7.
161. Rahman MM, Bhattacharya A, Banu J, Fernandes G. Conjugated linoleic acid protects against age-associated bone loss in C57BL/6 female mice. J Nutr Biochem. 2007;18:467-474.